Skip to content
healthcare.dev

Eribulin Mesylate

NDC 10019-080, Eribulin Mesylate, injection, from Baxter Healthcare Company.

Product NDC
10019-080
Status
Listed
Labeler
Baxter Healthcare Company
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217250
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10019-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
10019-080-01100190080011 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/62690292-b1de-46f1-b6e8-012a725f8c63
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=10019-080

Use it

Look up 10019-080 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10019-080 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10019-080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.